Table 6 Treatment and outcome - Entities mainly prevalent in infants (A)
From: Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany
Patient No. | Mechanical ventilation | Surfactant treatment, response | O2 supply at rest | Immuno-suppressive treatment | Response to treatment | Long term out-come** |
|---|---|---|---|---|---|---|
1 | Yes* | yes; good | 1 l/min | Systemic steroids | good but transient | died |
2 | Yes* | n.k. | n.k. | Systemic steroids; Azathioprin; Hydroxychloroquin | good; good; good | n.k. |
3 | Yes* | yes, good | 100% | Systemic steroids | none | died |
4 | Yes* | yes, good | 30-100% | Systemic steroids; Chloroquin | good; none | died |
5 | Yes | n.k. | 2 l/min | Systemic steroids; Hydroxychloroquin | none; none | died |
6 | No | n.k. | 2 l/min | Systemic steroids | n.k. | alive |
7 | No | n.k. | no | Systemic steroids | good | n.k. |
8 | n.k. | n.k. | 4 l/min | Systemic steroids | n.k. | alive |
9 | Yes* | yes, none | 80-100% | Systemic steroids | n.k. | died |
10 | Yes* | yes, none | transient | Systemic steroids | good | alive |
11 | Yes* | yes, good | 1 l/min | Systemic steroids | good but transient | alive |
12 | Yes* | yes, good | transient | No steroids | alive | |
13 | No | n.k. | n.k. | n.k. | n.k. | |
14 | Yes* | yes, none | transient | No steroids | alive | |
15 | No* | no | 1-2 l/min | Systemic steroids | good | n.k. |
16 | No | no | n.k. | n.k. | n.k. | |
17 | No* | n.k. | n.k. | n.k. | ||
18 | Yes* | n.k. | n.k. | n.k. | ||
19 | No | no | 0,7-2 l/min | Systemic steroids | n.k. | alive |
20 | Yes | no | 1 l/min | No steroids | alive | |
21 | No | n.k. | 2 l/min | Systemic steroids | good | alive |